4th Liquid Biopsy for Precision Oncology East Coast

The 4th Liquid Biopsy for Precision Oncology East Coast explores advancements in liquid biopsy technologies for precision oncology, addressing standardization, regulatory challenges, and clinical applications.

Key Topics

• Maximizing the impact of liquid biopsies to enhance ADC safety and efficacy
• Establishing standardized and optimized frameworks for reliable results
• Empowering pathology through collaboration and digital innovation
• Overcoming cost and reimbursement barriers for sustainable commercialization
• Driving early intervention and personalized monitoring with biomarker innovation
• Advancing MRD as a surrogate endpoint for streamlined trial readouts
• Alleviating regulatory complexities to accelerate market entry
• Smashing barriers in pre-analytical and clinical validation

Who should Attend

• Regulatory professionals
• Oncologists
• Biomarker scientists
• Clinical trial managers
• Pathologists
• Diagnostics developers
• Healthcare executives
• Precision medicine researchers
• Pharmaceutical industry leaders
• Medical technology specialists